Dubai: Dubai’s Roads and Transport Authority (RTA) has announced the permanent closure of the Tamam Al Ghandi Vehicle Testing and Registration Centre in Ras Al Khor, effective January 1, 2026. In a ...

UAE’s coldest spot hits 3.5°C as mountain destination pauses operations for safety Dubai: Anyone planning a hike or winter outing at Jebel Jais this week will need to put plans on hold. The UAE’s ...

PESHAWAR: Vice-chancellor Khyber Medical University Prof Dr Ziaul Haq has been appointed executive director of Higher Education Commission (HEC) Islamabad. Prof Ziaul Haq is not only the youngest ...

President Donald Trump and Australian Prime Minister Anthony Albanese signed an agreement on critical minerals that Albanese said includes plans for projects worth a total of up to $8.5 billion.

ACHIEVING CRITICAL MINERAL AND ENERGY DOMINANCE: Today, President Donald J. Trump and Australian Prime Minister Anthony Albanese signed a landmark Critical Minerals Framework to unleash the potential ...

The Higher Education Commission (HEC) has announced an extension in the application deadline for the Commonwealth Scholarships 2025–26, allowing more students to apply for this prestigious ...

Several of Maharashtra’s premier institutions, including the Indian Institute of Technology (IIT) Bombay, University of Mumbai, Savitribai Phule Pune University (SPPU), and Dr DY Patil University, ...

The government will set up a Maharashtra-Australia Innovation and Skills Hub (MAISH) to link the state's industrial and educational ecosystem with Australian expertise, Higher and Technical Education ...

https://www.thehindubusinessline.com/companies/hec-infra-projects-bags-two-projects-worth-12-crore/article69974139.ece Copy HEC Infra Projects, a leading engineering ...

Photo Credit: Phillipa Harrison, the new CEO of Ras Al Khaimah Tourism Development Authority (RAKTDA). Ras Al Khaimah Tourism Development Authority Ras Al Khaimah on Monday named Phillipa Harrison as ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.